Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
71 EUR | -13.41% |
|
-14.46% | -25.65% |
03:52pm | CARL ZEISS MEDITEC AG : Receives a Buy rating from DZ Bank | ZD |
02:06pm | Goldman rates Carl Zeiss Meditec at 'Sell' - Target 90 euros | DP |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With an expected P/E ratio at 29.59 and 23.87 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.56 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-25.65% | 8.07B | - | ||
+6.68% | 218B | B | ||
+10.01% | 189B | B- | ||
+27.38% | 151B | B- | ||
+32.11% | 113B | A- | ||
-0.15% | 64.02B | A- | ||
+13.58% | 52.6B | B+ | ||
+1.85% | 49.85B | B+ | ||
-5.84% | 37.89B | A | ||
+0.10% | 34.92B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AFX Stock
- AFXA Stock
- Ratings Carl Zeiss Meditec AG